Literature DB >> 17502755

Pathogenesis, management, and prevention of recurrent pericarditis.

Massimo Imazio1, Rita Trinchero, Ralph Shabetai.   

Abstract

Recurrent pericarditis is one of the most troublesome complications of acute pericarditis and, despite recent advances, remains one of the most challenging problems in pericardial diseases. The exact recurrence rate is unknown, but a reasonable estimate is 30%. The diagnosis is based on clinical criteria, and only routine laboratory testing is required. In many, probably most cases, this is an autoimmune disease, but sometimes it is caused by reactivation of viral pericarditis, an unrelated infection, or is provoked by corticosteroid therapy. Therapeutic modalities are non-specific and varied, and usually the etiology is autoimmunity. Non-steroidal anti-inflammatory drugs with the possible addition of colchicine are the best first-choice treatment, before steroid therapy is tried. Corticosteroid therapy is an independent risk factor for recurrences. In order to provide an evidence-based clinical approach to management, we performed a systematic review of all publications on acute and recurrent pericarditis focusing on recent clinical trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502755     DOI: 10.2459/01.JCM.0000269708.72487.34

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  10 in total

Review 1.  Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis.

Authors:  Massimo Imazio; Yehuda Adler
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 2.  Recurrent Pericarditis: Modern Approach in 2016.

Authors:  Massimo Imazio; Yehuda Adler; Philippe Charron
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

3.  Acute and recurring pericarditis: More colchicine, less corticosteroids.

Authors:  Paul Farand; Francis Bonenfant; Emilie P Belley-Côté; Nicholas Tzouannis
Journal:  World J Cardiol       Date:  2010-12-26

4.  Diagnostic potential of an enzyme-linked immunospot assay in tuberculous pericarditis.

Authors:  E Bathoorn; A Limburg; J J Bouwman; A W Bossink; S F Thijsen
Journal:  Clin Vaccine Immunol       Date:  2011-03-30

Review 5.  Multimodality imaging of pericardial disease.

Authors:  Paul C Cremer; Deborah H Kwon
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

6.  Recurrent postoperative effusive-constrictive pericarditis associated with steroid discontinuation.

Authors:  Gyung-Min Park; Jong-Young Lee; Yong-Giun Kim; Sun-Jin Boo; Jong-Min Song; Duk-Hyun Kang; Jae-Kwan Song
Journal:  J Cardiovasc Ultrasound       Date:  2009-09-30

Review 7.  Diagnosis and management of pericardial diseases.

Authors:  Massimo Imazio; Antonio Brucato; Rita Trinchero; Yehuda Adler
Journal:  Nat Rev Cardiol       Date:  2009-10-27       Impact factor: 32.419

8.  Current and emerging strategies for the treatment of acute pericarditis: a systematic review.

Authors:  Samar Sheth; Dee Dee Wang; Christos Kasapis
Journal:  J Inflamm Res       Date:  2010-11-25

Review 9.  Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis.

Authors:  Luca Cantarini; Massimo Imazio; Maria Giuseppina Brizi; Orso Maria Lucherini; Antonio Brucato; Rolando Cimaz; Mauro Galeazzi
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 10.817

10.  Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population.

Authors:  David Lin; François Laliberté; Christine Majeski; Matt Magestro; Dominique Lejeune; Mei Sheng Duh; Michelle Lim-Watson; John F Paolini
Journal:  Adv Ther       Date:  2021-08-21       Impact factor: 3.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.